Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Novel bispecific immunoadhesin shows promise for HIV prevention and immunotherapy

July 26, 2016

Targeting Tat expression pathways may be useful for reactivation of latent HIV-1

July 26, 2016

EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada

July 25, 2016

ABX-464 well tolerated in first study in HIV-infected patients, another under way

July 22, 2016

Heterodimeric interleukin-15 can reduce viral reservoirs in SIV-infected macaques

July 21, 2016

FDA approves Prezista expanded prescribing information

July 19, 2016

NIH expands investment to advance basic medical research toward HIV cure

July 15, 2016

Vaccine Technologies HIV vaccine LFn-p24B/C displays immunogenicity in phase I study

July 14, 2016

Gilead Sciences and Institute of Organic Chemistry and Biochemistry patent anti-HIV agents

July 12, 2016

Gilead Sciences describes HIV reverse transcriptase inhibitors

July 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...